Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04364620
Title AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alethia Biotherapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.